Veeco Instruments Inc. filings document the regulatory record for a semiconductor process equipment manufacturer serving advanced semiconductor fabrication and packaging applications. Form 8-K reports cover operating and financial results, earnings-release exhibits, material-event disclosures and capital-structure information.
Proxy and annual meeting filings describe Veeco's governance framework, director elections, shareholder voting matters, stock incentive plan proposals, auditor ratification and advisory executive-compensation votes. The filings also provide formal disclosure context for the company's common stock, board oversight, material agreements and risks tied to semiconductor equipment markets and customer demand.
Veeco Instruments Inc. furnished its third‑quarter 2025 results, posting a press release and conference call presentation as Exhibits 99.1 and 99.2. The company also outlined next steps for a proposed merger with Axcelis Technologies, Inc., under which a wholly owned Axcelis subsidiary would merge into Veeco and Veeco would survive as a wholly owned subsidiary of Axcelis.
Axcelis plans to file a Form S‑4 that will include a joint proxy statement/prospectus for the shares to be issued in the transaction. The merger remains subject to regulatory and stockholder approvals and other closing conditions. The filing includes forward‑looking statements highlighting risks around approvals, integration, costs, and potential impacts on customers, suppliers, and employees.
Veeco Instruments Inc. furnished its third‑quarter 2025 results, posting a press release and conference call presentation as Exhibits 99.1 and 99.2. The company also outlined next steps for a proposed merger with Axcelis Technologies, Inc., under which a wholly owned Axcelis subsidiary would merge into Veeco and Veeco would survive as a wholly owned subsidiary of Axcelis.
Axcelis plans to file a Form S‑4 that will include a joint proxy statement/prospectus for the shares to be issued in the transaction. The merger remains subject to regulatory and stockholder approvals and other closing conditions. The filing includes forward‑looking statements highlighting risks around approvals, integration, costs, and potential impacts on customers, suppliers, and employees.
Veeco Instruments Inc. filed a current report describing a new U.S. export control rule affecting certain China-related business. On September 29, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security issued the so‑called Affiliates Rule, which expands the list of companies subject to U.S. list-based export restrictions. This rule will limit manufacturers’ ability to export certain products and provide specific parts and services to some China-based customers without a license.
After a preliminary review, Veeco states that it does not expect the Affiliates Rule to have a material impact on its currently anticipated China-based business. The company also clarifies that this information is being furnished rather than filed under the Exchange Act, which affects how it is treated for certain legal liability purposes.
Adrian Devasahayam, identified as SVP - Product Line Development at Veeco Instruments Inc. (VECO), reported an insider sale. The filing discloses a sale on 10/02/2025 of 3,851 shares of Veeco common stock at a price of $34 per share. After the reported transaction the filing shows 78,269.208 shares beneficially owned (direct). The Form 4 was signed by an attorney-in-fact on 10/03/2025.
William John Miller, who is listed as CEO and a Director of Veeco Instruments Inc. (VECO), reported a sale of common stock on 10/01/2025. The Form 4 shows 25,000 shares were disposed of at a reported price of $32 per share. After the sale, the filing reports 514,543 shares beneficially owned by the reporting person. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.
Form 144 filing for Veeco Instruments, Inc. (VECO) reports a proposed sale of 3,851 common shares through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $130,934 and approximately 60,161,823 shares outstanding. The filer acquired the shares through restricted stock vesting and employee stock purchase plan (ESPP) transactions between 09/14/2020 and 06/30/2022; purchase/payment methods were compensation and cash. The form also discloses two recent sales by the same person on 09/15/2025 (4,046 shares, $105,196) and 09/23/2025 (4,014 shares, $120,420). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Form 144 notice for Veeco Instruments, Inc. (VECO) reporting a proposed sale of 25,000 common shares. The shares are to be sold through Wells Fargo Clearing Services on the Nasdaq with an aggregate market value shown as $799,493.00, against 60,161,823 shares outstanding, and an approximate sale date of 10/01/2025. The filer reports the shares were acquired on 03/18/2024 as grants from the issuer and that 25,000 shares were previously sold on 09/09/2025 by William J Miller for gross proceeds of $624,493.00. Several standard filer and issuer identification fields and the署名/remarks fields are present but not populated in the provided content.
Veeco Instruments and Axcelis Technologies agreed an Acquisition Agreement dated September 30, 2025 under which Axcelis will acquire Veeco in a merger expected to close in 2026, subject to customary closing conditions. Holders of vested Veeco RSUs will have those awards canceled and receive the Merger Consideration for the shares underlying each vested RSU plus any accrued dividend equivalents in cash. Unvested Veeco RSUs will be assumed by Axcelis and converted into Axcelis RSUs covering whole shares based on the Exchange Ratio, with accrued dividend equivalents preserved. Veeco director RSAs that are not vested will become fully vested and canceled with holders receiving the Merger Consideration. Closing conditions include Nasdaq listing approval for Axcelis stock issuance, expiration/termination of the HSR waiting period, PRC regulatory approval, effectiveness of a Form S-4 registration statement, accuracy of material representations and warranties (subject to exceptions), covenants compliance, and absence of a material adverse effect for each company. The filing also references a Fifth Amendment to Veeco's loan agreement and a joint press release dated October 1, 2025.
Insider sale recorded: SVP Adrian Devasahayam reported a sale of 4,014 shares of Veeco Instruments Inc. common stock on 09/23/2025 at a reported price of $30 per share. After the transaction, the reporting person beneficially owned 82,120.208 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/24/2025.
Veeco Instruments (VECO) Notice of Proposed Sale (Form 144) reports an intended sale of 4,014 common shares with an aggregate market value of $120,420 to be sold on 09/23/2025 through Fidelity Brokerage Services on NASDAQ. The shares were acquired by the seller via restricted stock vesting in 2021 (2,129 on 03/17/2021; 1,202 on 05/04/2021; 683 on 06/16/2021) as compensation. The filing also discloses a recent sale on 09/15/2025 of 4,046 shares for gross proceeds of $105,196. The form includes the standard representation that the seller has no undisclosed material adverse information.
Veeco Instruments (VECO) Notice of Proposed Sale (Form 144) reports an intended sale of 4,014 common shares with an aggregate market value of $120,420 to be sold on 09/23/2025 through Fidelity Brokerage Services on NASDAQ. The shares were acquired by the seller via restricted stock vesting in 2021 (2,129 on 03/17/2021; 1,202 on 05/04/2021; 683 on 06/16/2021) as compensation. The filing also discloses a recent sale on 09/15/2025 of 4,046 shares for gross proceeds of $105,196. The form includes the standard representation that the seller has no undisclosed material adverse information.
Insider sale reported: Veeco Instruments SVP Adrian Devasahayam sold 4,046 shares of Veeco common stock on 09/15/2025 at $26.00 per share, reducing his beneficial ownership to 86,134.208 shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025.